IL2 and neuroblastoma: To further address the challenges of using modified MSCs to treat tumors, we generated a human adipose tissue-derived MSCs line (hADSCs) stably expressing IL2, to determine the effects of MSC-mediated IL2 delivery on SH-SY5Y neuroblastoma cell growth and immune modulation in vitro.